• LAST PRICE
    2.8100
  • TODAY'S CHANGE (%)
    Trending Up0.1800 (6.8441%)
  • Bid / Lots
    2.8200/ 2
  • Ask / Lots
    2.8500/ 1
  • Open / Previous Close
    2.8900 / 2.6300
  • Day Range
    Low 2.7500
    High 2.9600
  • 52 Week Range
    Low 2.2100
    High 12.0000
  • Volume
    51,006
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 2.63
TimeVolumeLIPO
09:32 ET36562.85
09:33 ET3492.9
09:42 ET1002.93
09:44 ET30132.8817
09:46 ET3002.915
09:48 ET3702.93
09:50 ET12502.9101
09:51 ET20332.9053
09:55 ET3002.96
10:00 ET9222.89
10:04 ET2002.95
10:06 ET3002.925
10:08 ET1002.95
10:09 ET1002.91
10:11 ET25002.9001
10:20 ET10092.84
10:22 ET3002.8396
10:24 ET1492.8
10:26 ET13762.75
10:27 ET34372.8
10:38 ET2502.7658
10:54 ET20002.7834
10:58 ET5552.78
11:02 ET2992.79
11:05 ET3002.8
11:14 ET1852.8059
11:20 ET1002.81
11:30 ET1302.8101
11:34 ET2002.83
11:36 ET15992.85
11:38 ET1822.85
11:56 ET1002.835
12:03 ET1002.85
12:08 ET2002.84
12:17 ET1932.8366
12:24 ET2622.84
12:26 ET6372.8395
12:50 ET5612.83
12:53 ET9222.78
01:08 ET3002.81
01:33 ET7432.8099
01:44 ET1002.81
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesLIPO
Lipella Pharmaceuticals Inc
3.2M
-0.6x
---
United StatesBDRX
Biodexa Pharmaceuticals PLC
2.7M
0.0x
---
United StatesAPM
Aptorum Group Ltd
4.2M
-0.8x
---
United StatesCYCC
Cyclacel Pharmaceuticals Inc
2.2M
0.0x
---
United StatesPALI
Palisade Bio Inc
3.2M
-0.2x
---
United StatesADTX
Aditxt Inc
3.0M
0.0x
---
As of 2024-11-25

Company Information

Lipella Pharmaceuticals Inc. is a clinical-stage biotechnology company. It is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. Its lead product candidates include LP-10, LP-310 and LP-410. LP-10 is the development name of its reformulation of tacrolimus specifically optimized for topical deposition to the internal surface of the urinary bladder lumen using a proprietary drug delivery platform. LP-310 is the development name of its oral, liposomal formulation of tacrolimus specifically optimized for local delivery to oral mucosa. It is also developing an oral, liposomal formulation of tacrolimus, LP-410, for the treatment of oral graft-versus-host disease (GVHD). LP-410 is an oral rinse, like LP-310, but has a different containment system. LP-410 targets the underlying mechanisms of oral GVHD, potentially providing a safe and effective treatment option for affected individuals.

Contact Information

Headquarters
400 N Lexington St Ste Ll103PITTSBURGH, PA, United States 15208
Phone
412-901-0315
Fax
302-658-3694

Executives

Chairman of the Board, President, Chief Executive Officer, Treasurer, Secretary
Jonathan Kaufman
Chief Financial Officer
Douglas Johnston
Chief Medical Officer, Director
Micheal Chancellor
Independent Director
Lori Birder
Independent Director
Daniel Cohen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.2M
Revenue (TTM)
$507.2K
Shares Outstanding
1.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-4.95
Book Value
$4.16
P/E Ratio
-0.6x
Price/Sales (TTM)
6.3
Price/Cash Flow (TTM)
---
Operating Margin
-839.15%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.